Delivery Order SPE2DB20D3103-SPE2DB24FM4V0
Award Date
1/30/24
Potential Completion Date
1/31/24
Potential Value
$1.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Doxorubicin Liposome 50mg/25ml, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,500.00 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on February 9, 2024, with a completion date of February 12, 2024. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal healthcare programs,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The $5,400.00 fixed-price delivery order is for the supply of 4,564,081,943 units of Doxorubicin Liposome 20mg/10ml 10ml, a specialty pharmaceutical product, with a performance period through March 27, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up...
This federal contract award is for the delivery of 4559936723 - Doxorubicin Liposome 50mg/25ml, 25ml. The contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on February 14, 2023. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $2,467.98 and a completion date of February 15, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award to Amerisourcebergen Drug Corp (Amerisourcebergen) is a Delivery Order under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $1,500.00. The contract is for the delivery of 4563492985 - Doxorubicin Liposome 50mg/25ml, a specialty pharmaceutical product, to support military healthcare programs. Amerisourcebergen, a major pharmaceutical distributor and healthcare solutions provider, holds a $999,999,999 IDC...
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a Delivery Order contract worth $1,726.81 to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 50 mg Doxorubicin vials. This Delivery Order contract is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen provides a comprehensive range of pharmaceutical...
This federal contract award is for the delivery of DOXIL 50 MG/25 ML VIAL 25ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., doing business as Amerisourcebergen. The contract has a firm fixed price of $20,383.96 and a completion date of January 11, 2024. This award is not designated as a set-aside contract. Amerisourcebergen holds a significant Indefinite Delivery...
The Defense Logistics Agency (DLA) awarded a $1,691.20 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4564010703 ! DOXIL 20 MG/10 ML VIAL 10ML. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00, which serves as Amerisourcebergen's primary contract vehicle to provide pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $10,633.80 firm fixed-price delivery order is for the supply of Doxil 50 mg/25 ml vials, with a completion date of December 30, 2021. The contract does not have a set-aside designation, indicating it was competitively awarded. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that serves as a critical supplier to the U.S. Department of...
This federal contract award, with ID SPE2DX15D1053|SPE2DX24F6NSY, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4564898430 - Doxorubicin 200 mg/100 ml vials, with a firm fixed price ceiling value of $2,141.85 and a period of performance ending on June 14, 2024. Amerisourcebergen, a major pharmaceutical distribution company, has an Indefinite Delivery Contract...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Doxil 50 mg/25 ml vials. The order has a potential value of $3,051.42 and a completion date of December 28, 2023. Amerisourcebergen Drug Corp is a prime contractor that has received multiple federal contract awards from DLA Troop Support Medical to provide pharmaceuticals, medical supplies, and distribution...